yap inhibitor super tdu tfa (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
yap inhibitor super tdu tfa
Yap Inhibitor Super Tdu Tfa, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1727/Super-TDU/pmc07343472-163-0-11
Average 93 stars, based on 7 article reviews
Yap Inhibitor Super Tdu Tfa, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1727/Super-TDU/pmc07343472-163-0-11
Average 93 stars, based on 7 article reviews
yap inhibitor super tdu tfa - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Migration:Article Title: PPP1CA promotes hepatocellular carcinoma progression in a YAP1-dependent way. Article Snippet: Hepatocellular carcinoma (HCC) exhibits high incidence, malignancy, and mortality rates.. Inactivation of the Hippo pathway has been implicated in the acquisition of malignant characteristics in HCC.. The present study identifies upregulation of protein phosphatase 1 catalytic subunit alpha (PPP1CA) in HCC tissues, with elevated PPP1CA expression correlating with poor prognosis in patients with HCC. Functional Assay:Article Title: PPP1CA promotes hepatocellular carcinoma progression in a YAP1-dependent way. Article Snippet: Hepatocellular carcinoma (HCC) exhibits high incidence, malignancy, and mortality rates.. Inactivation of the Hippo pathway has been implicated in the acquisition of malignant characteristics in HCC.. The present study identifies upregulation of protein phosphatase 1 catalytic subunit alpha (PPP1CA) in HCC tissues, with elevated PPP1CA expression correlating with poor prognosis in patients with HCC. Concentration Assay:Article Title: PPP1CA promotes hepatocellular carcinoma progression in a YAP1-dependent way. Article Snippet: Hepatocellular carcinoma (HCC) exhibits high incidence, malignancy, and mortality rates.. Inactivation of the Hippo pathway has been implicated in the acquisition of malignant characteristics in HCC.. The present study identifies upregulation of protein phosphatase 1 catalytic subunit alpha (PPP1CA) in HCC tissues, with elevated PPP1CA expression correlating with poor prognosis in patients with HCC. Saline:Article Title: PPP1CA promotes hepatocellular carcinoma progression in a YAP1-dependent way. Article Snippet: Hepatocellular carcinoma (HCC) exhibits high incidence, malignancy, and mortality rates.. Inactivation of the Hippo pathway has been implicated in the acquisition of malignant characteristics in HCC.. The present study identifies upregulation of protein phosphatase 1 catalytic subunit alpha (PPP1CA) in HCC tissues, with elevated PPP1CA expression correlating with poor prognosis in patients with HCC. other:Article Title: Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel Article Snippet: Cell Culture:Article Title: Mechanosensing regulates pDC activation in the skin through NRF2 activation. Article Snippet: Plasmacytoid DCs (pDCs) infiltrate the skin, chronically produce type I interferon (IFN-I), and promote skin lesions and fibrosis in autoimmune patients.. However, what controls their activation in the skin is unknown.. Here, we report that increased stiffness inhibits the production of IFN-I by pDCs. |